Literature DB >> 17975027

Chromosomal biomarkers for detection of human papillomavirus associated genomic instability in epithelial cells of cervical cytology specimens.

Irina Sokolova1, Alicia Algeciras-Schimnich, Minghao Song, Svetlana Sitailo, Frank Policht, Benjamin R Kipp, Jesse S Voss, Kevin C Halling, Adam Ruth, Walter King, Dawn Underwood, Jennifer Brainard, Larry Morrison.   

Abstract

The goal of this study was to compare how accumulation of chromosomal aberrations in human papillomavirus (HPV)-infected cells correlates with the severity of cervical dysplastic lesions. We assessed the frequency of genomic alterations for 35 different loci in a pilot biopsy study and selected two loci (3q26 and 8q24) with the highest frequency of copy number gains found in high-grade dysplasia and cancer. These probes were labeled with gold and red fluorophores and combined with HPV biotin-labeled probes for subsequent detection using a tyramide signal amplification system with a green fluorophore. Cells that were both HPV positive and chromosomally abnormal were designated as "double-positive cells." Cervical cytology specimens from 235 patients were used for this blinded study. The average number of double-positive cells increased from two cells in patients with a cytological interpretation of atypical squamous cells of undetermined significance to 22 cells in low-grade squamous intraepithelial lesion and 99 cells in high-grade squamous intraepithelial lesion, reflecting an accumulation of chromosomal abnormality with disease progression. Using a cutoff of four or more double-positive cells as the criterion for the presence of a cervical intraepithelial neoplasia 2 or 3 lesion, we demonstrated that low-grade squamous intraepithelial lesion and high-grade squamous intraepithelial lesion cytology specimens with underlying cervical intraepithelial neoplasia 2/3 histology showed positive test results in more than 80% of cases. Correlation of 3q26 and 8q24 aneusomy with concurrent HPV infection may thus serve as a biomarker of genetic instability in HPV-infected cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17975027      PMCID: PMC2049051          DOI: 10.2353/jmoldx.2007.070007

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  32 in total

Review 1.  Fluorescence in situ hybridization analysis of biomarkers in cancer.

Authors:  H F Mark
Journal:  Exp Mol Pathol       Date:  1999-12       Impact factor: 3.362

2.  The application of comparative genomic hybridization to previously karyotyped cervical cancer cell lines.

Authors:  A Thein; M Trková; M Fox; J Parrington
Journal:  Cancer Genet Cytogenet       Date:  2000-01-01

3.  Adding a test for human papillomavirus DNA to cervical-cancer screening.

Authors:  Thomas C Wright; Mark Schiffman
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

4.  Human papillomavirus infection, centrosome aberration, and genetic stability in cervical lesions.

Authors:  B Skyldberg; K Fujioka; A C Hellström; L Sylvén; B Moberger; G Auer
Journal:  Mod Pathol       Date:  2001-04       Impact factor: 7.842

5.  Human papilloma virus status and chromosomal imbalances in primary cervical carcinomas and tumour cell lines.

Authors:  A Hidalgo; C Schewe; S Petersen; M Salcedo; P Gariglio; K Schlüns; M Dietel; I Petersen
Journal:  Eur J Cancer       Date:  2000-03       Impact factor: 9.162

6.  Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.

Authors:  D Solomon; M Schiffman; R Tarone
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

7.  Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia.

Authors:  Kerstin Heselmeyer-Haddad; Viktor Janz; Philip E Castle; Nadia Chaudhri; Nicole White; Kim Wilber; Larry E Morrison; Gert Auer; Frances H Burroughs; Mark E Sherman; Thomas Ried
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

8.  Genomic changes and HPV type in cervical carcinoma.

Authors:  C P Matthews; K A Shera; J K McDougall
Journal:  Proc Soc Exp Biol Med       Date:  2000-03

9.  Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection.

Authors:  Anju Zhang; Susanne Månér; Regina Betz; Tord Angström; Ulf Stendahl; Frank Bergman; Anders Zetterberg; Keng-Ling Wallin
Journal:  Int J Cancer       Date:  2002-10-10       Impact factor: 7.396

10.  Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members.

Authors:  Stefan Duensing; Karl Münger
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more
  11 in total

1.  Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears.

Authors:  Sonia Andersson; Pavani Sowjanya; Darawalee Wangsa; Anders Hjerpe; Bo Johansson; Gert Auer; Patti E Gravitt; Catharina Larsson; Keng-Ling Wallin; Thomas Ried; Kerstin Heselmeyer-Haddad
Journal:  Am J Pathol       Date:  2009-11       Impact factor: 4.307

2.  Genome-wide screening of DNA copy number alterations in cervical carcinoma patients with CGH+SNP microarrays and HPV-FISH.

Authors:  Petr Kuglik; Jan Smetana; Vladimira Vallova; Lucie Moukova; Katerina Kasikova; Michaela Cvanova; Lucie Brozova
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

3.  Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.

Authors:  Shaomin Chen; Ziyan Yang; Yun Zhang; Yunbo Qiao; Baoxia Cui; Youzhong Zhang; Beihua Kong
Journal:  Diagn Pathol       Date:  2012-04-13       Impact factor: 2.644

4.  c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasia.

Authors:  Kirsten Kübler; Sally Heinenberg; Christian Rudlowski; Mignon-Denise Keyver-Paik; Alina Abramian; Sabine Merkelbach-Bruse; Reinhard Büttner; Walther Kuhn; Hans-Ulrich Schildhaus
Journal:  Oncotarget       Date:  2015-01-20

5.  Three Prime Repair Exonuclease 1 (TREX1) expression correlates with cervical cancer cells growth in vitro and disease progression in vivo.

Authors:  Bruna Prati; Walason da Silva Abjaude; Lara Termini; Mirian Morale; Suellen Herbster; Adhemar Longatto-Filho; Rafaella Almeida Lima Nunes; Lizeth Carolina Córdoba Camacho; Silvia Helena Rabelo-Santos; Luiz Carlos Zeferino; Francisco Aguayo; Enrique Boccardo
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

6.  The detection of hTERC amplification using fluorescence in situ hybridization in the diagnosis and prognosis of cervical intraepithelial neoplasia: a case control study.

Authors:  Geping Yin; Juan Li; Tongyu Zhu; Xiaoli Zhao
Journal:  World J Surg Oncol       Date:  2012-08-21       Impact factor: 2.754

7.  Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.

Authors:  Hongqian Liu; Shanling Liu; He Wang; Xiaoyan Xie; Xinlian Chen; Xuemei Zhang; Youcheng Zhang
Journal:  Diagn Pathol       Date:  2012-10-30       Impact factor: 2.644

8.  3q26 amplification is an effective negative triage test for LSIL: a historical prospective study.

Authors:  Erica R Heitmann; Kamani M Lankachandra; Jeff Wall; George D Harris; Hollie J McKinney; G Reza Jalali; Yogita Verma; Eric Kershnar; Michael W Kilpatrick; Petros Tsipouras; Diane M Harper
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

9.  An Optimization-Driven Analysis Pipeline to Uncover Biomarkers and Signaling Paths: Cervix Cancer.

Authors:  Enery Lorenzo; Katia Camacho-Caceres; Alexander J Ropelewski; Juan Rosas; Michael Ortiz-Mojer; Lynn Perez-Marty; Juan Irizarry; Valerie Gonzalez; Jesús A Rodríguez; Mauricio Cabrera-Rios; Clara Isaza
Journal:  Microarrays (Basel)       Date:  2015-06

Review 10.  Human papillomavirus and genome instability: from productive infection to cancer.

Authors:  Bruna Prati; Bruna Marangoni; Enrique Boccardo
Journal:  Clinics (Sao Paulo)       Date:  2018-09-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.